以第一作者或通讯作者发表SCI论文92篇，总影响因子363.7分，最高单篇影响因子24.54分。

1.       Zhang Z^#, Zhang B^#, Wang X^#, Zhang X, Yang QX, Qing Z, Zhang W, Zhu D^#, Bi Y*. Olfactory Dysfunction Mediates Adiposity in Cognitive Impairment of Type 2 Diabetes: Insights From Clinical and Functional Neuroimaging Studies. Diabetes Care. 2019 Jul;42(7):1274-1283. (IF=15.27)

2.       Wang H^#, Shen L^#, Sun X^#, Liu F^#, Feng W, Jiang C, Chu X, Ye X, Jiang C, Wang Y, Zhang P, Zang M, Zhu D^#, Bi Y*. Adipose group 1 innate lymphoid cells promote adipose tissue fibrosis and diabetes in obesity. Nat Commun. 2019 Jul 22;10(1):3254. (IF=11.878)

3.      Zhu D^#, Gan S, Liu Y, Ma J, Dong X, Song W, Zeng J, Wang G, Zhao W, Zhang Q, Li Y, Fang H, Lv X, Shi Y, Tian H, Ji L, Gao X, Zhang L, Bao Y, Lei M, Li L, Zeng L, Li X, Hou X, Zhao Y, Hu T, Ge X, Zhao G, Li Y, Zhang Y, Chen L*. Dorzagliatin monotherapy in Chinese patients with type 2 diabetes: a dose-ranging, randomised, double-blind, placebo-controlled, phase 2 study. Lancet Diabetes Endocrinol, 2018 Aug;6(8):627-636. (IF=24.54)

4.     Zhang P^#, Ge Z^#, Wang H^#, Feng W, Sun X, Chu X, Jiang C, Wang Y, Zhu D*, Bi Y*. Prolactin improves hepatic steatosis via CD36 pathway. J Hepatol, 2018 Jun;68(6):1247-1255. (IF=18.946)

5.      Ling Q^#, Lu J^#, Li J, Xu Q, Zhu D*, Bi Y*. Risk of beta-cell autoimmunity presence of progression to type 1 diabetes: a systemic review and meta-analysis. J Autoimmu, 2018 Jan;86:9-18. (IF=7.543)

6.      Zhang Z^#, Zhang B^#, Wang X^#, Zhang X, Yang QX, Qing Z, Lu J, Bi Y*, Zhu D*. Altered Odor-Induced Brain Activity as an Early Manifestation of Cognitive Decline in Patients with Type 2 Diabetes. Diabetes, 2018 May;67(5):994-1006. (IF=7.199)

7.      Gu T^#, Ma J^#, Zhang Q^#, Zhu L^#, Zhang H, Xu L, Cheng J, Shi B, Li D, Shao J, Sun Z, Zhong S, Bi Y*, Zhu D*. Comparative effect of saxagliptin and glimepiride with a composite endpoint of adequate glycemic control without hypoglycemia and without weight gain in patients uncontrolled with metformin therapy: Results from the SPECIFY study, a 48-week, multi-centre, randomized, controlled trial. Diabetes Obes Metab, 2018 Dec 5. doi: 10.1111/dom.13605. (IF=6.133)

8.    Feng B^#, Meng R^#, Huang B, Bi Y, Shen S, Zhu D*. Silymarin protects against renal injury through normalization of lipid metabolism and mitochondrial biogenesis in high fat-fed mice. Free Radic Biol Med, 2017 Sep; 110: 240-249. (IF=6.02) 

9.      Xu W, Bi Y^#, Sun Z, Li J, Guo L, Yang T, Wu G, Shi L, Feng Z, Qin L, Guo X, Luo Z, Lu JM, Shan Z, Yang W, Ji Q, Yan L, Li H, Yu X, Li S, Zhou Z, Lv X, Liang Z, Lin S, Zeng L, Yan J, Ji L*, Weng J*. Comparison of the effects on glycaemic control and β-cell function in newly diagnosed type 2 diabetes patients of treatment with exenatide, insulin or pioglitazone: a multicentre randomized parallel-group trial (the CONFIDENCE study). J Intern Med, 2015, 277(1):137-150. (IF=7.803)

10.    Zhang M, Tong G^#, Liu Y, Mu Y, Weng J, Xue Y, Luo Z, Xue Y, Shi L, Wu X, Sun S, Zhu Y, Cao Y, Zhang J, Huang H, Niu B, Li H, Guo Q, Gao Y, Li Z, Ning G, Zhu D*, Li X*; HHIS Study Group. Sequential Versus Continual Purified Urinary FSH/hCG in Men With Idiopathic Hypogonadotropic Hypogonadism. J Clin Endocrinol Metab, 2015, 100(6): 2449-55. (IF=5.531)

11.    Bi Y^#, Wu W, Shi J, Liang H, Yin W, Chen Y, Tang S, Cao S, Cai M, Shen S, Gao Q, Weng J, Zhu D*. Role for sterol regulatory element-binding protein-1c activation in mediating skeletal muscle insulin resistance via repressing insulin receptor substrate-1 transcription. Diabetologia, 2014, 57(3):592-602. (IF=6.206)

12.    Gu W, Hu J, Wang W, Li L, Tang W, Sun S, Cui W, Ye L, Zhang Y, Hong J, Zhu D*, Ning G*. Diabetic ketoacidosis at diagnosis influences complete remission after treatment with hematopoietic stem cell transplantation in adolescents with type 1 diabetes. Diabetes Care, 2012, 35(7):1413-9. (IF=8.934)

13.    Bi Y^#, Zeng L, Zhu D*, Yan J, Zhang Y, Tong G, Mu P, Shen S, Hu Y, Yu Q, Liang H, Weng J*. Association of β-cell function and insulin sensitivity with fasting and 2-h plasma glucose in a large Chinese population. Diabetes Obes Metab, 2012, 14(2):174-80. (IF=6.198)

14.    Li L^#, Shen S^#, Ouyang J, Hu Y, Hu L, Cui W, Zhang N, Zhuge Y, Chen B, Xu J, Zhu D*. Autologous Hematopoietic Stem Cell Transplantation Modulates Immunocompetent Cells and Improves Beta Cell Function in Chinese Patients with New Onset of Type 1 Diabetes. J Clin Endocrinol Metab, 2012, 97(5):1729-1726. (IF=5.531)